Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Truist Securities Downgrades Forte Biosciences to Hold

Truist Securities analyst Nicole Germino downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Hold.

September 3, 2021

1 minute read

Truist Securities analyst Nicole Germino downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Hold.

‘FSCDems wanted to ban Payment for Order Flow but couldn’t amid pushback from @FinancialCmte GOP and moderates who said the system allows for discount trading and has democratized the markets…’ -Tweet From FOX’s Charlie Gasparino

Today, 6:12 AM

https://twitter.com/CGasparino/status/1427342271461085186

Today, 6:12 AM

DA Davidson analyst Franco Granda initiates coverage on ironSource (NYSE:IS) with a Buy rating and announces Price Target of $11.

Today, 6:12 AM

Morgan Stanley analyst Courtney Yakavonis maintains United Rentals (NYSE:URI) with a Underweight and raises the price target from $268 to $275.

Today, 6:12 AM

Some 137,000 Bitcoin (CRYPTO: BTC) are to be released into crypto markets from funds associated with 2011’s Mt. Gox hack.